JHIU
LPCN icon

Janus Henderson Investors US’s Lipocine LPCN Stock Holding History

Janus Henderson Investors US’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-18,024
Closed -$1.87M – 1125
2014
Q3 		$1.87M Sell
18,024
-31,553
-64% -$3.92M ﹤0.01% 906
2014
Q2 		$5.14M Buy
+49,577
New +$5.93M ﹤0.01% 784

Other funds holding LPCN

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Janus Henderson Investors US's LPCN Position: Q4 2014 in Review

Janus Henderson Investors US sold out of Lipocine (LPCN) in Q4 2014, closing a stake of 18,024 shares — an estimated $1.87M sold.

Janus Henderson Investors US first reported a position in LPCN in Q2 2014 and held it in 2 quarters. The position peaked at $5.14M in Q2 2014. 22 funds tracked by Wall St. Rank hold LPCN as of Q4 2014.

  • Janus Henderson Investors US reported no remaining Lipocine position as of Q4 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 18,024 Lipocine shares in Q4 2014, an estimated $1.87M.
  • Janus Henderson Investors US first reported a position in Lipocine in Q2 2014 and held it in 2 quarters.
  • Janus Henderson Investors US's Lipocine position peaked at $5.14M in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Lipocine as of Q4 2014.

Based on Janus Henderson Investors US's 13F filing for Q4 2014, filed 18 Feb 2015.